• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种 Fab 恒定结构域被一对 CH3 结构域替换的抗体。

An antibody with Fab-constant domains exchanged for a pair of CH3 domains.

机构信息

Christian Doppler Laboratory for Innovative Immunotherapeutics, Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.

Institute of Molecular Modeling and Simulation, Department of Material Sciences, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.

出版信息

PLoS One. 2018 Apr 9;13(4):e0195442. doi: 10.1371/journal.pone.0195442. eCollection 2018.

DOI:10.1371/journal.pone.0195442
PMID:29630643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5891013/
Abstract

We have designed a complete antibody-like construct where the CH1 and Cκ domains are exchanged for a pair of the CH3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immunoglobulin sequences without artificial linkers, expressed at a high level in mammalian cells, however exhibited low solubility. Rational mutagenesis aimed at the amino acid residues located at the interface of the variable domains and the exchanged CH3 domains was applied to improve the biophysical properties of the molecule. The domain-exchanged construct, including variable domains of the HER2/neu specific antibody trastuzumab, was able to bind to the surface of the strongly HER2/neu positive cell line SK-BR3 4-fold weaker than trastuzumab, but could nevertheless incite a more potent response in an antibody-dependent cell cytotoxicity (ADCC) reporter assay with FcγRIIIa-overexpressing T-cells. This could be explained with a stronger binding to the FcγRIIIa. Importantly, the novel construct could mediate a specific ADCC effect with natural killer cells similar to the parental antibody.

摘要

我们设计了一种完整的抗体样构建体,其中 CH1 和 Cκ 结构域被一对 CH3 结构域取代,并且通过“Knobs-into-Holes”策略实现了重链和轻链可变区的有效配对。该构建体仅由天然存在的免疫球蛋白序列组成,没有人工接头,在哺乳动物细胞中高水平表达,但表现出低溶解度。为了改善分子的物理化学性质,我们对位于可变区和交换的 CH3 结构域界面的氨基酸残基进行了合理的突变。包括曲妥珠单抗(HER2/neu 特异性抗体)可变区的结构域交换构建体,与 SK-BR3 细胞系(表面高度表达 HER2/neu)的结合能力比曲妥珠单抗弱 4 倍,但在 FcγRIIIa 过表达 T 细胞的抗体依赖性细胞细胞毒性(ADCC)报告试验中,仍能引起更强的反应。这可以用与 FcγRIIIa 的更强结合来解释。重要的是,新型构建体可以与自然杀伤细胞介导特异性 ADCC 效应,类似于亲本抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/9fbc51ab94ff/pone.0195442.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/b4d4f4bb3e6e/pone.0195442.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/55f61b85841c/pone.0195442.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/9837b170a6ad/pone.0195442.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/d1b0a13a5397/pone.0195442.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/9fbc51ab94ff/pone.0195442.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/b4d4f4bb3e6e/pone.0195442.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/55f61b85841c/pone.0195442.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/9837b170a6ad/pone.0195442.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/d1b0a13a5397/pone.0195442.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc80/5891013/9fbc51ab94ff/pone.0195442.g005.jpg

相似文献

1
An antibody with Fab-constant domains exchanged for a pair of CH3 domains.一种 Fab 恒定结构域被一对 CH3 结构域替换的抗体。
PLoS One. 2018 Apr 9;13(4):e0195442. doi: 10.1371/journal.pone.0195442. eCollection 2018.
2
Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.新型双 Fc 抗体的设计与鉴定,增强了对 Fc 受体的亲和力。
Proteins. 2020 May;88(5):689-697. doi: 10.1002/prot.25853. Epub 2019 Nov 20.
3
Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.在细菌中表达的选择性结合 FcγR I 的无糖基化 IgG 变体增强单核细胞-树突状细胞对肿瘤细胞的杀伤作用。
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):604-9. doi: 10.1073/pnas.0908590107. Epub 2009 Dec 18.
4
Engineered humanized dimeric forms of IgG are more effective antibodies.工程化的人源化二聚体形式的IgG是更有效的抗体。
J Exp Med. 1992 Oct 1;176(4):1191-5. doi: 10.1084/jem.176.4.1191.
5
Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.通过修饰恒定结构域对小鼠IgG1 Fab片段进行基于结构的稳定性工程改造。
J Mol Biol. 2006 Aug 25;361(4):687-97. doi: 10.1016/j.jmb.2006.06.073. Epub 2006 Jul 28.
6
Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies.恒定结构域交换 Fab 可实现异二聚体双特异性 SEED 抗体中特异性轻链配对。
Biochim Biophys Acta Proteins Proteom. 2020 Jan;1868(1):140250. doi: 10.1016/j.bbapap.2019.07.003. Epub 2019 Jul 8.
7
Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains.具有交换抗原结合恒定结构域的Fab臂的双特异性抗体。
Biochem Biophys Rep. 2021 Feb 27;26:100959. doi: 10.1016/j.bbrep.2021.100959. eCollection 2021 Jul.
8
Differential inhibition of trastuzumab- and cetuximab-induced cytotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes.不同 GM 同种型表达的免疫球蛋白 G1 对曲妥珠单抗和西妥昔单抗诱导的癌细胞细胞毒性的差异抑制。
Clin Exp Immunol. 2011 Dec;166(3):361-5. doi: 10.1111/j.1365-2249.2011.04477.x.
9
Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.鉴定对 FcγRIIIa 亲和力增加而对 FcγRI 和 FcRn 亲和力不变的 IgG(1)变体:基于可溶性受体和基于细胞的结合测定法的比较。
J Immunol Methods. 2011 Feb 28;365(1-2):132-41. doi: 10.1016/j.jim.2010.12.014. Epub 2010 Dec 23.
10
Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.MBS301 的结构和功能表征,一种去岩藻糖基化的双特异性抗 HER2 抗体。
MAbs. 2018 Aug/Sep;10(6):864-875. doi: 10.1080/19420862.2018.1486946. Epub 2018 Aug 6.

引用本文的文献

1
Design and engineering of bispecific antibodies: insights and practical considerations.双特异性抗体的设计与工程:见解与实际考量
Front Bioeng Biotechnol. 2024 Jan 25;12:1352014. doi: 10.3389/fbioe.2024.1352014. eCollection 2024.
2
Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains.具有交换抗原结合恒定结构域的Fab臂的双特异性抗体。
Biochem Biophys Rep. 2021 Feb 27;26:100959. doi: 10.1016/j.bbrep.2021.100959. eCollection 2021 Jul.
3
The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.

本文引用的文献

1
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.免疫球蛋白结构域界面交换作为生成Fc异二聚体和双特异性抗体的平台技术。
J Biol Chem. 2017 Jun 9;292(23):9745-9759. doi: 10.1074/jbc.M117.782433. Epub 2017 Apr 27.
2
Generation of human bispecific common light chain antibodies by combining animal immunization and yeast display.通过结合动物免疫和酵母展示技术生成人双特异性共同轻链抗体。
Protein Eng Des Sel. 2017 Apr 1;30(4):291-301. doi: 10.1093/protein/gzw077.
3
Advances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-life.
框架突变在 HIV-1 广谱中和抗体谱系中对抗体亲和力成熟的影响。
Front Immunol. 2020 Jul 17;11:1529. doi: 10.3389/fimmu.2020.01529. eCollection 2020.
4
Improved monovalent TNF receptor 1-selective inhibitor with novel heterodimerizing Fc.新型异二聚化 Fc 的改进型单价 TNF 受体 1 选择性抑制剂。
MAbs. 2019 May/Jun;11(4):653-665. doi: 10.1080/19420862.2019.1596512. Epub 2019 Mar 31.
治疗性Fc工程进展——IgG相关效应功能及血清半衰期的调控
Front Immunol. 2016 Dec 12;7:580. doi: 10.3389/fimmu.2016.00580. eCollection 2016.
4
A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.一种HER2特异性修饰的Fc片段(Fcab)通过HER2降解和凋亡诱导抗肿瘤作用。
Mol Ther. 2015 Nov;23(11):1722-1733. doi: 10.1038/mt.2015.127. Epub 2015 Aug 3.
5
Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI.人IgG1与其高亲和力人受体FcγRI结合的结构基础。
Nat Commun. 2015 Apr 30;6:6866. doi: 10.1038/ncomms7866.
6
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.用于改变与新生儿Fc受体结合的人IgG1的Fc工程影响Fc效应功能。
J Immunol. 2015 Jun 1;194(11):5497-508. doi: 10.4049/jimmunol.1401218. Epub 2015 Apr 22.
7
A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism.一种通过静电导向机制制备单价双特异性异源二聚体IgG抗体的新型抗体工程策略。
J Biol Chem. 2015 Mar 20;290(12):7535-62. doi: 10.1074/jbc.M114.620260. Epub 2015 Jan 12.
8
Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.开发一种基于报告基因的稳健的抗体依赖性细胞介导的细胞毒性(ADCC)检测方法,使用冻融即用型细胞来测量治疗性抗体的Fc效应子功能。
J Immunol Methods. 2014 Dec 1;414:69-81. doi: 10.1016/j.jim.2014.07.010. Epub 2014 Jul 31.
9
Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.改善双特异性抗体支架的物理化学性质以提高开发可行性:通过分子设计实现质量。
MAbs. 2013 Sep-Oct;5(5):646-54. doi: 10.4161/mabs.25632. Epub 2013 Jul 8.
10
IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.IgG2 Fc 结构和 IgG CH2-CH3 界面的动态特征。
Mol Immunol. 2013 Nov;56(1-2):131-9. doi: 10.1016/j.molimm.2013.03.018. Epub 2013 Apr 28.